pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·1d ago·1 min read
save

Harvard researchers keep brain organoids alive for five years, tracking development

Aug 18, 2026·read at Fierce Biotech ↗Positive

A study published in Nature describes how researchers at Harvard University grew a human brain organoid from a blood sample and kept it alive in the lab for five years.

During the five-year period the team monitored transcriptional and epigenomic changes, finding that the organoid’s cells aged in a pattern that mirrors post-natal human brain development.

The senior author, Paola Arlotta, said the model could spark a wave of new therapies, offering a bridge between laboratory research and patient-specific disease studies for biotech and industry.

The approach begins with a simple blood draw, from which stem cells are extracted and differentiated into brain tissue, providing a long-term, patient-derived platform for biomedical research.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “A ‘renaissance for biomedicine’: human brain organoids model development for 5 years”

read at Fierce Biotech ↗
669 words · retrieved 12h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE
topics
Hematology6

related stories

  • 14h agoKolon TissueGene cuts 37 US staffers after Phase 3 failBioSpace
  • Jul 31Catheter Introducer Kit Recall: Abiomed Removes 14Fr Low Profile Introducer Kitsfda medwatch
  • Jul 29‘Low tech’ chemotherapy nanoparticles show promise for deadly brain tumor recurrenceFierce Biotech
  • Jul 27Opinion: How midwives like me can help fight medical misinformationSTAT
  • Jul 24Amgen deploys patients to defend troubled Tavneos in FDA hearing requestBioSpace